0001209191-22-012720.txt : 20220224 0001209191-22-012720.hdr.sgml : 20220224 20220224163818 ACCESSION NUMBER: 0001209191-22-012720 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220224 DATE AS OF CHANGE: 20220224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Annoni Joe CENTRAL INDEX KEY: 0001910431 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 22671752 MAIL ADDRESS: STREET 1: C/O ATHENEX, INC. STREET 2: 1001 MAIN STREET, SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-18 0 0001300699 Athenex, Inc. ATNX 0001910431 Annoni Joe C/O ATHENEX, INC., 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 0.794 2022-02-18 4 A 0 50000 0.00 A 2032-02-18 Common Stock 50000 50000 D Restricted Stock Units 2022-02-18 4 A 0 50000 0.00 A Common Stock 50000 50000 D This option vests in four equal annual installments beginning on February 18, 2023. Each restricted stock unit represents the contingent right to receive one share of stock. The restricted stock units vest in four equal installments beginning on February 18, 2023. /s/Steven Adams, Attorney-in-Fact 2022-02-24